Japan’s Shionogi starts Phase II/III clinical trial for new COVID-19 vaccine

Japan's Shionogi starts Phase II/III clinical trial for new COVID-19 vaccine

TOKYO, Oct 21 (Reuters) – Japan’ Shionogi & Co Ltd (4507.T) said on Wednesday it had started a Phase II/III clinical trial for its COVID-19 vaccine candidate.The trial for the recombinant protein-based vaccine will take place in Japan and follows a Phase I trial in the country, Shionogi said in a statement. The company will … Read more

Pfizer Submits Favorable Initial Data To The FDA On Kids’ COVID-19 Vaccine Trial : Coronavirus Updates : NPR

Pfizer Submits Favorable Initial Data To The FDA On Kids' COVID-19 Vaccine Trial : Coronavirus Updates : NPR

Pfizer and BioNTech say they will submit a formal request for emergency use authorization of the vaccine in young children “in the coming weeks,” as they share data with the FDA about trials for kids from 5 up to 12. Here, a healthcare worker administers a dose of the vaccine to an older child at … Read more